A leaflet for parents and carers about the use of methylphenidate (brand names: Ritalin, Rubifen) for attention deficit hyperactivity disorder (ADHD).
Treatment with medicines is part of a comprehensive treatment programme for ADHD that includes behavioural therapy. The diagnosis of ADHD must have been confirmed by a specialist.
Download the pdf (pdf, 435kb) from the New Zealand Formulary for Children website
The leaflet is an adaptation of 'Medicines for children: Information for parents and carers' at medicinesforchildren.org.uk. The adaptation is by the New Zealand Formulary for Children.
Leaflets at the New Formulary for Children website are only available to users in New Zealand and its territories.